Sphingosine kinase 1 and pulmonary hypertension

Pyne, Nigel (Principal Investigator)
Pyne, Susan (Co-investigator)

Strathclyde Institute Of Pharmacy And Biomedical Sciences

Project: Research

Status	Finished
Effective start/end date	1/09/12 → 31/08/15

Funding

British Heart Foundation BHF: £183,012.00

Effect of the sphingosine kinase 1 selective inhibitor, PF-543 on arterial and cardiac remodeling in a hypoxic model of pulmonary arterial hypertension
MacRitchie, N., Volpert, G., Al Washih, M., Watson, D. G., Futerman, A. H., Kennedy, S., Pyne, S. & Pyne, N. J., 31 Aug 2016, In: Cellular Signalling. 28, 8, p. 946-955 10 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
39 Link opens in a new tab Citations (Scopus)

95 Downloads (Pure)